Neutrophil-lymphocyte ratio and carotid-intima media thickness in patients with behçet disease without cardiovascular involvement

Angiology

Volumn 66, Issue 3, 2015, Pages 291-296

  Ozturk, Cengiz ^a   Balta, Sevket ^b   Balta, Ilknur ^c   Demirkol, Sait ^a   Celik, Turgay ^a   Turker, Turker ^a   Iyisoy, Atila ^a   Eksioglu, Meral ^d  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ESKISEHIR MILITARY HOSPITAL   (Turkey)

^c Pediatric Hematology Oncology Clinic Eskisehir State Hospital   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Beh et disease; Carotid intima media thickness; Disease activity; Neutrophil lymphocyte ratio

Indexed keywords

C REACTIVE PROTEIN; AUTACOID; BIOLOGICAL MARKER;

ADULT; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTICLE; BEHCET DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; BEHCET SYNDROME; BLOOD; CASE CONTROL STUDY; COMMON CAROTID ARTERY; ECHOGRAPHY; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; NEUTROPHIL; PROGNOSIS;

ADULT; AREA UNDER CURVE; BEHCET SYNDROME; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE;

EID: 84925581617     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714527638     Document Type: Article

References (34)

1. Balta I, Akbay G, Kalkan G, Eksioglu M. Demographic and clinical features of 521 Turkish patients with Behçet's disease. Int J Dermatol. 2014;53(5):564-569.
2. Cekmen M, Evereklioglu C, Er H, et al. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Int J Dermatol. 2003;42(11):870-875.
3. Ekiz O, Balta I, Sen BB, et al. Mean Platelet Volume in Recurrent Aphthous Stomatitis and Behcet Disease. Angiology. 2014;65(2): 161-165.
4. Oztürk MA, Unverdi S, Oktar SO, et al. Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease. Clin Rheumatol. 2008;27(8):961-966.
5. Haznedaroglu E, Karaaslan Y, Büyükaşik Y, et al. Selectin adhesion molecules in Behçet's disease. Ann Rheum Dis. 2000; 59(1):61-63.
6. Balta S, Balta I, Demirkol S, Ozturk C, Demir M. Endothelial function and behcet disease. Angiology. 2014;65(8):657-659.
7. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek List. 2001;102(1):5-14.
8. Erayman A, Sen N. Neutrophil-lymphocyte ratio and C-reactive protein may be correlated in patients with coronary artery ectasia. Angiology. 2014;65(1):84-85.
9. Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638-1643.
10. Ishizu T, Ishimitsu T, Kamiya H, et al. The correlation of irregularities in carotid arterial intima-media thickness with coronary artery disease. Heart Vessel. 2002;17(1):1-6.
11. Criteria for diagnosis of Behçet's disease. International study group for Behçet's disease. Lancet. 1990;335(8697):1078-1080.
12. Balta I, Balta S, Koryurek OM, et al. Serum endocan levels as a marker of disease activity in patients with Behçet disease. J Am Acad Dermatol. 2014;70(2):291-296.
13. Suzuki Kurokawa M, Suzuki N. Behcet's disease. Clin Exp Med. 2004;4(1):10-20.
14. Balta S, Demirkol S, Cakar M, Arslan Z, Unlu M, Celik T. Other inflammatory markers should not be forgetten when assessing the neutrophil-to-lymphocyte ratio. Clin Appl Thromb Hemost. 2013;19(6):693-694.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
16. Türsen U. Pathophysiology of the Behçet's disease. Pathol Res Int. 2012;2012:493015.
17. Hong SN, Park JC, Yoon NS, et al. Carotid artery intimamedia thickness in Behcet's disease patients without significant cardiovascular involvement. Korean J Intern Med. 2008; 23(2):87-93.
18. Kiraz S, Ertenli I, Oztürk MA, Haznedaroʇ lu IC, Celik I, Calgüneri M. Pathological haemostasis and "prothrombotic state" in Behçet's disease. Thromb Res. 2002;105(2):125-133.
19. Kosar A, Haznedaroglu S, Karaaslan Y, et al. Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease. Rheumatol Int. 1999;19(1-2):11-14.
20. Balta I, Balta S, Koryurek OM, et al. Mean platelet volume is associated with aortic arterial stiffness in patients with Behçet's disease without significant cardiovascular involvement. J Eur Acad Dermatol Venereol. 2014;28(10):1388-1393.
21. Balta I, Balta S, Demirkol S, et al. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol. 2013; 169(5):1066-1070.
22. Cingoz F, Iyisoy A, Demirkol S, et al. Carotid intima-media thickness in patients with slow coronary flow and its association with neutrophil-to-lymphocyte ratio: a preliminary report. Clin Appl Thromb Hemost. 2014;20(4):393-399.
23. Sarli B, Baktir AO, Saglam H, et al. Neutrophil-to-lymphocyte ratio is associated with severity of coronary artery ectasia. Angiology. 2014;65(2):147-151.
24. Fici F, Celik T, Balta S, et al. Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension. J Cardiovasc Pharmacol. 2013;62(4): 388-393.
25. Balta S, Demirkol S, Unlu M, Arslan Z, Celik T. Neutrophil to lymphocyte ratio may be predict of mortality in all conditions. Br J Cancer. 2013;109(12):3125-3126.
26. Balta S, Demirkol S, Celik T, et al. Association between coronary artery ectasia and neutrophil-lymphocyte ratio. Angiology. 2013; 64(8):627-632.
27. Macey M, Hagi-Pavli E, Stewart J, et al. Age, gender and diseaserelated platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease. Rheumatology (Oxford). 2011;50(10):1849-1859.
28. Neves FS, Carrasco S, Goldenstein-Schainberg C, Gonçalves CR, de Mello SBV. Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses. Clin Rheumatol. 2009;28(12):1403-1410.
29. Ahsen A, Ulu MS, Yuksel S, et al. As a New inflammatory marker for familial mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation. 2013;36(6):1357-1362.
30. Celikbilek M, Dogan S, Ozbakir O, et al. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal. 2013;27(1):72-76.
31. AygündüzM, Bavbek N, Oztürk M, Kaftan O, Koşar A, Kirazli S. Serum beta 2-microglobulin reflects disease activity in Behçet's disease. Rheumatol Int. 2002;22(1):5-8.
32. Sari RA, Kiziltunç A, Taysi S, Akdemir S, Gündoʇdu M. Levels of soluble E-selectin in patients with active Behcet's disease. Clin Rheumatol. 2005;24(1):55-59.
33. Curnow SJ, Pryce K, Modi N, et al. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis? Immunol Lett. 2008;121(1):7-12.
34. Sarican T, Ayabakan H, Turkmen S, Kalaslioglu V, Baran F, Yenice N. Homocysteine: an activity marker in Behçet's disease? J Dermatol Sci. 2007;45(2):121-126.